Logo image of AVNS

AVANOS MEDICAL INC (AVNS) Stock Analyst Ratings

USA - NYSE:AVNS - US05350V1061 - Common Stock

11.24 USD
+0.12 (+1.08%)
Last: 11/18/2025, 8:04:00 PM
11.24 USD
0 (0%)
After Hours: 11/18/2025, 8:04:00 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to AVNS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.34. This target is 54.27% above the current price.
AVNS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about AVNS.
In the previous month the buy percentage consensus was at a similar level.
AVNS was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

AVNS Historical Analyst RatingsAVNS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 11.2417.1717.3417.3417.85 - 52.76% 54.27% 54.27% 58.81%

Related screens

AVNS Current Analyst RatingAVNS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-05-07 JMP Securities Reiterate Market Perform
2023-07-25 Keybanc Downgrade Overweight -> Sector Weight
2023-06-21 Stifel Reiterate Hold -> Hold
2023-05-22 CL King Initiate Buy
2023-05-04 Morgan Stanley Maintains Underweight
2023-02-22 Morgan Stanley Maintains Underweight
2023-01-06 Morgan Stanley Maintains Underweight
2022-11-03 Keybanc Maintains Overweight
2022-10-11 Morgan Stanley Maintains Underweight
2022-08-10 Keybanc Maintains Overweight
2022-07-18 Stifel Maintains Hold
2022-07-15 Morgan Stanley Maintains Underweight
2022-05-05 Morgan Stanley Maintains Underweight
2022-02-24 Keybanc Maintains Overweight
2022-01-07 Morgan Stanley Maintains Underweight
2021-08-04 Keybanc Maintains Overweight
2021-08-04 Stephens & Co. Downgrade Overweight -> Equal-Weight
2021-08-04 Morgan Stanley Maintains Underweight

AVANOS MEDICAL INC / AVNS FAQ

What do analysts expect the price target to be for AVANOS MEDICAL INC (AVNS)?

6 analysts have analysed AVNS and the average price target is 17.34 USD. This implies a price increase of 54.27% is expected in the next year compared to the current price of 11.24.


What is the consensus rating for AVANOS MEDICAL INC (AVNS) stock?

The consensus rating for AVANOS MEDICAL INC (AVNS) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for AVNS stock?

The number of analysts covering AVANOS MEDICAL INC (AVNS) is 6.